Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/12/2003US20030108942 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108918 Inactivated vaccines for aids and other infectious diseases
06/12/2003US20030108889 Mutations; cloning; immunoglobulins; genetic engineering
06/12/2003US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/12/2003US20030108570 Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis
06/12/2003US20030108563 Blood screening for hepatitis C virus; complexing
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108553 Detection and treatment of cancers of the liver
06/12/2003US20030108551 Brain disorders; Alzheimer's disease; Down syndrome; hybridomas cell line; medical diagnosis
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108548 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
06/12/2003US20030108546 Apoptosis-inducing single-chain Fv
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108518 TRX1 antibody and uses therefor
06/12/2003US20030108516 Death domain containing receptor 4
06/12/2003CA2847885A1 Transgenic animals bearing human ig.lambda. light chain genes
06/12/2003CA2811997A1 Antibodies against monocyte chemotactic proteins
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/12/2003CA2469087A1 Compositions and methods for producing vascular occlusion
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468744A1 Hybrid antibodies
06/12/2003CA2468733A1 Antibodies against monocyte chemotactic proteins
06/12/2003CA2468678A1 Modulation of immune-cell related disorders using il-1hy2
06/12/2003CA2468565A1 Transgenic animals bearing human iglambda light chain genes
06/12/2003CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003CA2468259A1 Antibody to latent membrane proteins and uses thereof
06/12/2003CA2467738A1 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003CA2467597A1 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003CA2467363A1 Polycistronic expression of antibodies
06/12/2003CA2464897A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/11/2003EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
06/11/2003EP1318195A1 A structure for presenting desired peptide sequences
06/11/2003EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
06/11/2003EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
06/11/2003EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
06/11/2003EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
06/11/2003EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/11/2003EP1317540A2 Imidazoline receptor homologs
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
06/11/2003EP1317527A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317486A1 Interferon-alpha induced gene
06/11/2003EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
06/11/2003EP1317479A2 Methods and compositions for diseases associated with amyloidosis
06/11/2003EP1317478A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II
06/11/2003EP1317476A2 Reagents for cell selection and methods of use
06/11/2003EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/11/2003EP1317310A1 Use of serum response factor (srf) modulator for treating srf related diseases
06/11/2003EP1317285A1 Methods for treating demyelinating diseases
06/11/2003EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
06/11/2003EP0848755B1 Vegf-related protein
06/11/2003EP0782863B1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof
06/11/2003EP0759997B1 Use of tetracycline promoter for the strictly regulated production of recombinant proteins in prokaryotic cells
06/11/2003EP0690873B1 Growth differentiation factor-8
06/11/2003EP0673417B1 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL $g(b)-BARREL
06/11/2003EP0665886B1 Cyclin complex rearrangement and uses related thereto
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423697A Virulence genes and proteins and their use
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1423660A Antibodies
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423561A Remedies for hepatitis C
06/11/2003CN1423523A Human ex vivo immune system
06/11/2003CN1422864A Zinc finger protein and its antibody preparation and use
06/10/2003US6576812 Compound screening assays using a transgenic mouse model of human skin diseases
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576754 Genetically engineered nucleic acids; proteins, fusion proteins and active fragments stimulate leukocyte response
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576607 Methods using CNS neurite outgrowth modulators
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576442 rdgB proteins and related products and methods
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576432 That bind integrin; can use in controlling cell adhesion
06/10/2003US6576431 Treatment for myocardial infarction; enhancing clot lysis
06/10/2003US6576427 Human cartilage glycoprotein
06/10/2003US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus
06/10/2003US6576240 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
06/10/2003US6576238 Isolated protein selected from protein having specified amino acid sequence, or protein comprising homologue of flea protein comprising portion of specified amino acid sequence, which elicits antibody response against flea protein
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003US6575751 Interactive dental restorative network
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
1 ... 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 ... 1494